ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2004

Reimbursement of glitazones in treatment of type 2 diabetes patients in Denmark in the context of a voluntary system for submitting pharmacoeconomic studies.

Hindrik Vondeling et al.PubMed ↗Publisher ↗

No numbers read from the abstract.